Live feed08:15:16·22mSECFilingvia QuantisnowNeumora Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Costs Associated with Exit or Disposal ActivitiesByQuantisnow·Wall Street's wire, on your screen.NMRA· Neumora Therapeutics Inc.Health CareOriginal source
